Free Trial
NASDAQ:TTRX

Turn Therapeutics Q1 2026 Earnings Results & Report

Turn Therapeutics logo
$8.59 -0.76 (-8.14%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Turn Therapeutics reported Q1 2026 earnings on May 11, 2026. The company reported EPS of -$0.03.

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
After Market Closes
Conference Call
4:00 PM ET

Turn Therapeutics EPS Results

Actual EPS
-$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Turn Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Turn Therapeutics Q1 2026 Earnings FAQ

Turn Therapeutics (NASDAQ:TTRX) reported earnings of -$0.03 per share for Q1 2026. The report was announced on Monday, May 11, 2026.

Turn Therapeutics Earnings Headlines

I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
Turn Therapeutics Inc. GAAP EPS of -$0.21
See More Turn Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Turn Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Turn Therapeutics and other key companies, straight to your email.

About Turn Therapeutics

Turn Therapeutics (NASDAQ:TTRX) is a biotechnology company focused on developing topical products for skin health, wound care and infection management. Its work centers on formulations intended to deliver antimicrobial treatment directly to affected areas.

The company has developed products for wound care and other topical applications, using its formulation technology to address needs in dermatology and related fields. Turn Therapeutics is based in the United States and has focused on developing and commercializing its products in the U.S. market.

View Turn Therapeutics Profile